Professor Schito is a Professor Practice in Law at Arizona Law and the Executive Director of the Critical Path Institute's CURE Drug Repurposing Collaboratory where his work aims to discover repurposed therapies for diseases with high unmet medical need by capturing and sharing global, real-world clinical data. Prior to joining the Critical Path Institute, Dr. Schito was a Senior Scientific Officer at the Division of AIDS, NIH and also worked at the National Cancer Institute where he led the in vivo modeling of anti-retroviral zinc finger inhibitors. Over the past decade, Professor Schito established data knowledgebase to enable the use of Next Generation Sequencing platforms to quickly and accurately identify efficacious tuberculosis drug regimens. This platform is now being used by the World Health Organization for their global genomic drug surveillance program. His work (https://scholar.google.de/citations?user=7KNlILQAAAAJ&hl=en) has been published in leading journals, including the Lancet Infectious Diseases, Nature Immunology, and the New England Journal of Medicine. Dr. Schito received his PhD from the Ontario Veterinary College at the University of Guelph, Canada in immuno-parasitology.
Professor Schito teaches LAW 577A Development & Innovation in Biologics, Devices, & Diagnostics during the Spring term.
Visit our YouTube Channel for a course video trailer https://bit.ly/3gSB3FQ